Photo: Thomas M. Barwick INC/Getty Images
WellTheory, a virtual care company for individuals with autoimmune diseases, has scored $14 million in Series A funding, bringing its total raise to $26.2 million.
General Catalyst led the round, with participation from new and existing investors 7wire Ventures, Box Group, Ingeborg Investments, Up2 Opportunity Fund and Accel.
WHAT IT DOES
WellTheory is a virtual care platform focused on autoimmune diseases. It offers care teams for individuals with various conditions, including lupus, fibromyalgia, Crohn's disease, multiple sclerosis, celiac disease, hypothyroidism, rheumatoid arthritis, Graves' disease and more.
The company will use the funds for commercial growth, to expand its programs for employers and payers, and to speed up AI development.
"As someone who’s lived with autoimmune disease, I know how broken and impersonal the system can feel. We’re using AI to change that — not to replace care, but to deepen it. By combining technology with empathy, we’re making it possible to deliver personalized, root-cause care to millions who’ve spent too long feeling unseen," Ellen Rudolph, CEO and cofounder of WellTheory, told MobiHealthNews.
MARKET SNAPSHOT
In June, WellTheory announced its first payer partnership with Sentara Health, a not-for-profit integrated healthcare system. Through the deal, WellTheory will offer Sentara Health Plans’ nearly one million members in Virginia and Florida access to a care team providing 12 months of autoimmune care.
Two months earlier, the company announced it had raised $5 million in funding and was rolling out two new tools, Care Scribe and Care Hub.
Care Scribe is an AI assistant that helps care teams with transcribing conversations, drafting follow-up notes and creating personalized care plans.
Care Hub aggregates member data, lab insights and session history, and helps with pre- and post-session tasks. It also enables automated compliance tracking.
In December, WellTheory launched a women's health program focused on hormonal conditions, including endometriosis, menopause and PCOS.
In 2023, the company formed its first employer partnership with Maven Clinic to offer the virtual women and family health provider's employees access to nutrition and lifestyle coaching from WellTheory.
The company launched in 2022 with $7.2 million in seed funding.
